{
  "chapter": "Ans Pharmacology-Previous Year Questions",
  "questions": [
    {
      "q_no": 1,
      "question": "Which of the following drugs exacerbates myasthenia and is usually avoided in a patient with myasthenia gravis? Lidocaine Digene Meropenem Phenytoin",
      "options": {
        "A": "1 & 2",
        "B": "2 & 3",
        "C": "1 & 3",
        "D": "1 only"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - 1 & 2 Lidocaine is a local anesthetic that may worsen myasthenia gravis by affecting neuromuscular function, potentially increasing weakness and fatigue due to its interference with acetylcholine receptors. Digene (antacid) contains magnesium or aluminum salts, which can reduce the absorption of medications like pyridostigmine, commonly used in myasthenia gravis, to enhance muscle strength. Drugs aggravating myasthenia gravis: Local Anaesthetics Magnesium Antibiotics: Aminoglycosides, Quinolones, Macrolides Beta-blockers Botulinum toxin Penicillamine Quinine derivatives NDMR Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 1044 Harrison’s Principles of Internal Medicine, 21st Edition, Page 3239",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 2,
      "question": "Dopamine at low doses causes:",
      "options": {
        "A": "Increases in cardiac contractility",
        "B": "Vasoconstriction",
        "C": "Tachycardia",
        "D": "Increases renal blood flow"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer D - Increases renal blood flow. At low doses, dopamine primarily acts on dopaminergic receptors (D1) in the renal and mesenteric vasculature, leading to vasodilation and an increase in renal blood flow. Action of Dopamine: Dopamine Dose Receptor Activation Effects < 2 µg/kg/min D1 receptors Increases renal blood flow; vasodilation in renal and mesenteric vessels 2-10 µg/kg/min β 1 receptors (heart) Increases heart rate (positive chronotropic) and contractility (positive inotropy) > 10 µg/kg/min α 1 receptors Vasoconstriction (increased systemic vascular resistance) and increased blood pressure Reference: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition, Pages 255-260.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 3,
      "question": "A child, after disturbing a bee hive, experienced several stings. A few minutes later, the child developed breathing difficulty and hypotension. What is the drug of choice for managing this child?",
      "options": {
        "A": "Dobutamine",
        "B": "Adrenaline",
        "C": "Noradrenaline",
        "D": "Dopamine"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Adrenaline Adrenaline (Epinephrine) is the first-line treatment for anaphylactic reactions caused by bee stings, as it quickly reverses symptoms by acting on alpha and beta receptors, helping to improve airway patency and increase blood pressure. Anaphylaxis is a Type I Hypersensitivity reaction. Adrenaline works on all adrenergic receptors and is commonly used in anaphylactic shock in a diluted form, typically a 1:1000 concentration (1 mg of adrenaline in 1 mL of solution). It is administered intramuscularly because, in shock conditions, peripheral blood flow is reduced. If the intramuscular injection does not show a response, intravenous administration may be considered. Uses of Epinephrine Condition Use Dilution/Concentration Route of Administration Anaphylaxis First-line treatment for severe allergic reactions 1:1000 (1 mg/mL) Intramuscular (IM) Cardiac arrest To restore cardiac rhythm and blood pressure 1:10,000 (0.1 mg/mL) Intravenous (IV) Intraosseous (IO) Asthma Treatment of acute severe asthma attacks 1:1000 (1 mg/mL) Inhalation via nebulizer Intramuscular (IM) subcutaneous (SC) Hypotension To increase blood pressure 1:100,000 (0.01 mg/mL) Intravenous (IV) infusion Local anesthesia Enhance duration and intensity of the local anaesthetic effect 1:200,000 to 1:100,000 (0.005 to 0.01 mg/mL) Local injection Dobutamine (Option A): This is an inotropic agent used for short-term management of severe heart failure, especially after myocardial infarction or cardiac surgery. It is not indicated for anaphylaxis. Noradrenaline (Option C): Although it acts on alpha-1, alpha-2, and beta-1 receptors, it does not affect beta-2 receptors, which are crucial for bronchial dilation. Therefore, it is not suitable for treating anaphylactic shock, which requires bronchodilation. Dopamine (Option D): This drug is used in conditions like cardiogenic or septic shock, where it helps to improve renal blood flow and cardiac output. It does not have the bronchodilatory effect needed in anaphylaxis and does not cause tachycardia, as it primarily affects muscle tissues rather than nodal tissues. Reference: KD Tripathi Essentials of Medical Pharmacology, 8th Edition, Page 145 Goodman and Gilman, Pharmacologic Basis of Therapeutics, 14th Edition, Page 266",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 4,
      "question": "A 45-year-old female presents with muscle weakness, blurred vision after exertion, and ptosis, which improves after undergoing the edrophonium test. What is the most likely diagnosis?",
      "options": {
        "A": "Lambert Eaton syndrome",
        "B": "Myasthenia gravis",
        "C": "Guillain-Barré syndrome",
        "D": "Bronchial asthma"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Myasthenia gravis The presence of ptosis , muscle weakness , and blurred vision, along with a positive edrophonium (Tensilon) test, supports the diagnosis of MG. Edrophonium temporarily improves symptoms by inhibiting acetylcholinesterase, allowing more acetylcholine to bind to receptors. Edrophonium test (Tensilon test): It helps differentiate between myasthenic and cholinergic crises, which present with similar symptoms but require opposite treatments. Myasthenic crisis arises from inadequate acetylcholine at the neuromuscular junction. The cholinergic crisis results from excessive acetylcholine stimulation due to anticholinesterase medication overdose. The tensilon test involves the injection of 10 mg i.v. Edrophonium , a short-acting anticholinesterase agent. 2 mg i.v. Edrophonium → Observe for any adverse reactions → If no adverse reactions occur after 30–60 seconds, the remaining 8 mg is injected. Results: Myasthenia Gravis: Short-lasting improvement in muscle strength. Other Muscular Dystrophies: No improvement. Cholinergic crisis: No improvement or a worsening of their condition. Lambert Eaton syndrome (Option A) : This disorder is characterized by muscle weakness, but it primarily affects the proximal muscles and is caused by antibodies against presynaptic calcium channels, leading to reduced acetylcholine release. Unlike MG, symptoms of Lambert Eaton syndrome improve with activity rather than worsening. Guillain-Barré syndrome (Option C) : This is an acute polyneuropathy, typically triggered by an infection, leading to rapid progressive weakness, usually starting in the lower limbs and affecting both proximal and distal muscles. It is not associated with the symptoms described in this case. Bronchial asthma (Option D) : This condition primarily involves respiratory symptoms such as wheezing, shortness of breath, and coughing and is not related to the muscle weakness and ptosis seen in this patient. Reference: KD Tripathi Essentials of Medical Pharmacology, 8th Edition, Page 121-122 Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition, Page 230-231",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 5,
      "question": "Which of the options below acts as a selective alpha-1 receptor antagonist in medical practice?",
      "options": {
        "A": "Phenoxybenzamine",
        "B": "Phentolamine",
        "C": "Prazosin",
        "D": "Idazoxan"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Prazosin Prazosin is a selective alpha-1 receptor antagonist commonly used to treat hypertension and symptoms of benign prostatic hyperplasia. It works by blocking alpha-1 receptors, leading to vasodilation and a decrease in blood pressure. Classification of Alpha-blockers based on their receptor binding Types Drugs Non- competitive + irreversible type Phenoxybenzamine Competitive + reversible type Non-selective Phentolamine Ergotamine Ergotoxine Chlorpromazine Alpha 1 selective Drugs Location Effects Alpha 1 a Tamsulosin Silodosin Internal Urethral Sphincter Iris Ejaculation failure/retrograde ejaculation, miosis, increased urine outflow Alpha 1 b Alfuzosin Doxazosin Prazosin Terazosin Vascular Smooth Muscle Vasodilatation, reflex tachycardia, reduced GFR (thus leading to RAAS activation) Alpha 2 selective Yohimbine Idoxazon Central Nervous System Penile erection (used in depression with sexual dysfunction) Prazosin is a highly selective I 1 blocker. Side effects Postural hypotension (first dose effect) - due to alpha 1b receptor blockade on vascular smooth muscles Retrograde ejaculation: Due to alpha 1a receptors blockade on internal urethral sphincter Floppy iris syndrome: Due to the blockade of the alpha 1a receptor on the iris Reflex tachycardia occurs due to vasodilation. Uses Hypertension Benign prostatic hyperplasia Raynaud’s disease Scorpion Bite. Phenoxybenzamine (Option A) is a non-selective alpha blocker that primarily targets both alpha-1 and alpha-2 receptors. It is typically used to treat pheochromocytoma but is not a selective alpha-1 antagonist. Phentolamine (Option B) is also a non-selective alpha blocker , acting on both alpha-1 and alpha-2 receptors. It is used to manage hypertensive crises and pheochromocytoma. Idazoxan (Option D) is an alpha-2 receptor antagonist, not an alpha-1 antagonist. It is primarily used in research rather than clinical practice. Reference: KD Tripathi Essentials of Medical Pharmacology, 8th Edition, Page 142,154",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 6,
      "question": "The dose at which dopamine acts on beta-1 receptors is _________?",
      "options": {
        "A": "2-10 mcg/kg/min",
        "B": "<2 mcg/kg/min",
        "C": "10-20 mcg/kg/min",
        "D": ">20 mcg/kg/min"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) 2-10 mcg/kg/min Explanation: The dose at which dopamine acts on the Beta-1 receptor is 2-10 mcg/kg/min. Different effects of dopamine based on dose Dose Effects <2 mcg/kg/min Stimulated D1 and D2 receptors, which increased blood flow to the renal and mesenteric vessels 2-5 mcg/kg/min Dopamine acts on cardiac beta-1 receptors, which increases myocardial contractility. It is also used during cardiogenic shock. 5-15 mcg/kg/min Dopamine acts on alpha-1 receptors to increase peripheral vascular resistance. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 661",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 7,
      "question": "Which of the following is the most effective drug in smoking cessation?",
      "options": {
        "A": "Varenicline",
        "B": "Buspirone SR",
        "C": "Nicotine Gum",
        "D": "Rimonabant"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Varenicline Varenicline is a medication that is used to help people quit smoking. Mechanism of action: Binds to alpha-4, beta-2 nicotinic receptors in the brain and also inhibits dopaminergic activation via partial agonism, reducing cravings and withdrawal symptoms. Prevents nicotine stimulation of the mesolimbic dopamine system ,which is associated with nicotine addictio,n and blocks the ‘reward’ effect of smoking. More effective than other smoking cessation medications, including nicotine replacement therapy and bupropion Dosing - per oral 0.5 mg once daily from day 1 to 3 0.5 mg twice daily from day 4 to 7 1 mg twice daily after day 8 for 11 weeks. Side effects include nausea, headache, sleep disturbances, renal stones and some serious conditions such as Stevens-Johnson syndrome, erythema multiforme, photosensitivity and renal failure Buspirone SR (Option B) is anxiolytic that has been studied as an off-label treatment for smoking cessation due to its ability to reduce anxiety and stress, which can be triggers for smoking. Buspirone hydrochloride extended-release tablets (SR) are formulations of the drug that are designed to be released into the bloodstream slowly over time, allowing for once-daily dosing. This can be more convenient for patients who have difficulty adhering to multiple daily dosing regimens. Nicotine gum (Option C) is a form of nicotine replacement therapy that is designed to help people quit smoking by reducing the intensity of nicotine withdrawal symptoms. The gum allows for the absorption of nicotine through the lining of the mouth, which can help to reduce cravings and withdrawal symptoms. While nicotine replacement therapy can be effective in smoking cessation, it is usually less effective than varenicline. Nicotine gum may also have side effects, including mouth irritation and hiccups, and should not be used by people who have dental problems or jaw pain. Rimonabant (Option D) is a medication that was developed as an anti-obesity drug and was also studied for its potential in smoking cessation. It works by acting as an inverse agonist and blocking the CB1 receptor in the brain, which is involved in regulating appetite and addictive behaviors. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 46, 246, 247 Katzung Basics and Clinical pharmacology, 14th Edition, Pages 288, 383, 404, 589.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 8,
      "question": "Which of the following drugs can be used to treat open-angle glaucoma in a patient with bronchial asthma?",
      "options": {
        "A": "Latanoprost",
        "B": "Timolol",
        "C": "Gemeprost",
        "D": "Mannitol infusion"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Latanoprost Explanation: Latanoprost is a prostaglandin (PGF2 α ) analogue that is commonly used to lower intraocular pressure in open-angle glaucoma, and it can be used in patients with bronchial asthma as it is not associated with bronchospasm. Latanoprost MOA Alters ciliary muscle tension - improves aqueous humour outflow Advantages High efficacy Once daily application only No systemic side effects Disadvantages Expensive Adverse effects Blurring of vision Iris pigmentation Thickening and darkening of eyelashes Macular edema (in aphakic patients ) Drugs used in the management of glaucoma Drugs increasing trabecular outflow Miotics Dipivefrine, Epinephrine Bimatoprost Netarsidil Drugs increasing uveoscleral outflow PGF2 α analogue - Latanoprost Drugs decreasing aqueous humour production Carbonic anhydrase inhibitors - Acetazolamide Hyperosmotic agents Mannitol Urea Timolol (Option B) is a non-selective beta-blocker that can be used topically to treat glaucoma but it is contraindicated in patients with asthma and COPD as it can have systemic side effects and lead to bronchospasm. Gemeprost (Option C) is a PGE1 analogue that is used in the medical termination of pregnancy and not in glaucoma. Mannitol infusion (Option D) is used to treat acute angle closure glaucoma as it causes decongestion of the eyes via its osmotic action. It is not used for open-angle glaucoma.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 9,
      "question": "A patient presented with a history of multiple episodes of vomiting. He was given intravenous medication for the same. Later, he developed abnormal movements. Which of the following drugs can be used to treat him?",
      "options": {
        "A": "Hyoscine",
        "B": "Cyprohepptadine",
        "C": "Levodopa",
        "D": "Benzhexol"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Benzhexol Explanation: Based on the history and clinical features, the patient was most likely given IV Metoclopramide, after which he developed extra-pyramidal symptoms of abnormal movements, and Benzhexol, which is an anti-cholinergic, can be used to treat the same. Metoclopramide MOA Dopamine receptor antagonist; acts centrally as a prokinetic and anti-emetic. Side effects Extrapyramidal symptoms Acute dystonia - occurs shortly after IV injection Parkinson-like symptoms seen after weeks of therapy Irreversible tardive dyskinesia - occurs with chronic treatment Galactorrhoea Methemoglobinemia Management of extrapyramidal symptoms Discontinuation of the drug. Benzhexol - centrally acting anticholinergic agents. Restores cholinergic balance in the striatal interneurons. Hyoscine (Option A), also known as scopolamine, is primarily used to prevent and treat motion sickness and nausea. It does not specifically target or treat abnormal movements. Cyproheptadine (Option B) is an antihistamine often used for allergic conditions and appetite stimulation. It can sometimes be used off-label to treat serotonin syndrome, but it is not typically used for drug-induced abnormal movements. Levodopa (Option C) is a medication commonly used in the treatment of Parkinson's disease. It helps replenish dopamine levels in the brain. However, levodopa is not typically used to treat drug-induced abnormal movements caused by other medications. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, Page 330, 724, 992, 923, 937, 942 K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 460",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 10,
      "question": "The response on stimulation of the muscarinic receptor is _",
      "options": {
        "A": "Erection",
        "B": "Ejaculation",
        "C": "Bronchodilation",
        "D": "Increased myocardial contractility"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Erection: Erection is mediated by muscarinic receptors of parasympathetic system. Muscarinic receptors are involved in the parasympathetic control of penile erection (M3 receptor) . Stimulation of these receptors leads to the release of nitric oxide (NO) in the penile arteries and smooth muscle relaxation, resulting in increased blood flow to the erectile tissue and the subsequent achievement and maintenance of an erection. Ejaculation (Option B) is mediated by the adrenergic system ( I 1 receptor) Bronchodilation (Option C): Stimulation of muscarinic receptors primarily leads to bronchoconstriction , not bronchodilation. When muscarinic receptors are activated in the airways, smooth muscle contraction occurs, which narrows the airways and causes bronchoconstriction. Increased myocardial contractility (Option D): Muscarinic receptor stimulation has a negative chronotropic and inotropic effect on the heart. Activation of these receptors in the heart results in a decrease in heart rate (chronotropic effect) and a reduction in myocardial contractility (inotropic effect), thereby lowering the force of cardiac contraction. Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 114",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 11,
      "question": "Which of the following medications is most commonly used for maintenance therapy in opioid withdrawal?",
      "options": {
        "A": "Buprenorphine",
        "B": "Naloxone",
        "C": "Naltrexone",
        "D": "Acamprosate"
      },
      "correct_answer": "A",
      "explanation": "in maintenance therapy for opioid dependence. It helps manage withdrawal symptoms and cravings by binding to the same opioid receptors in the brain that full agonists like heroin or methadone do but with a ceiling effect that reduces the risk of misuse, respiratory depression, and overdose. Buprenorphine can be used alone or in combination with naloxone (as in Suboxone) to further deter misuse. It is an effective and widely used medication for maintenance therapy in opioid use disorder. Incorrect Options: Option B - Naloxone: Naloxone is an opioid antagonist that is primarily used as a rescue medication in cases of opioid overdose. It rapidly reverses the effects of opioids, particularly respiratory depression. However, naloxone is not used for maintenance therapy in opioid withdrawal, as it would precipitate withdrawal symptoms in individuals dependent on opioids. Option C - Naltrexone: Naltrexone is an opioid antagonist that is used in the maintenance treatment of opioid and alcohol dependence. For opioid dependence, naltrexone is used after detoxification to prevent relapse. It works by blocking the euphoric and sedative effects of opioids. While effective, it is not typically used during the initial withdrawal phase or for managing withdrawal symptoms but rather for relapse prevention in those who have already undergone detoxification. Option D - Acamprosate: Acamprosate is a medication used to help maintain abstinence in individuals with alcohol dependence. It works by modulating glutamatergic neurotransmission and is not used for opioid withdrawal or maintenance therapy. Acamprosate does not have any effect on opioid receptors and is specific to alcohol use disorder.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 12,
      "question": "A patient with diabetes developed postoperative urinary retention. Which of the following drugs can be used for short-term treatment of the condition?",
      "options": {
        "A": "Tamsulosin",
        "B": "Bethanechol",
        "C": "Terazosin",
        "D": "Methacholine"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Bethanechol Explanation: Bethanechol can be used for short-term treatment of postoperative urinary retention in a patient with diabetes. Bethanechol Bethanechol is a cholinergic agonist that stimulates muscarinic receptors, which are found primarily in the urinary and gastrointestinal tracts. MOA Mimics the effects of acetylcholine, which plays a crucial role in the parasympathetic nervous system, at muscarinic receptors. Upon stimulating muscarinic receptors, it promotes bladder muscle contraction, aiding in urine expulsion and reducing urinary retention. Clinical Usage Postoperative and Postpartum urinary retention with no actual obstruction. Neurogenic bladder. Symptomatic relief in congenital megacolon. Gastroesophageal reflux Side Effects Gastrointestinal: Belching, involuntary defecation. Urinary: Involuntary urination. Other: Flushing, sweating, hypotension. Contraindications Mechanical obstruction of the gastrointestinal or urinary tract. Asthma. Hypotension. Tamsulosin and terazosin (Option A and C) are alpha-1 adrenergic blockers primarily used to treat symptoms of benign prostatic hyperplasia (BPH), such as urinary hesitancy, urgency, and weak urinary flow. They relax smooth muscles in the prostate and bladder neck to facilitate urine flow. While these medications may be beneficial for BPH-related urinary symptoms, they may not be as effective in treating postoperative urinary retention. Methacholine (Option D) is not used for urinary retention. It is a cholinergic agonist primarily used in diagnostic tests to assess airway hyperreactivity, such as in the diagnosis of asthma. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 212",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 13,
      "question": "A patient was prescribed an antipsychotic drug, following which he developed Parkinsonism. Which of the following drugs can be given?",
      "options": {
        "A": "Trihexyphenidyl",
        "B": "Entacapone",
        "C": "Rasagiline",
        "D": "Pramipexole"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Trihexyphenidyl Explanation: Trihexyphenidyl can be prescribed to a patient who has developed parkinsonism as a side effect of antipsychotic medication. It is an anticholinergic medication commonly used to treat parkinsonism and reduce the symptoms associated with extra-pyramidal symptoms. Reduction in dopamine and an increase in acetylcholine levels together is responsible for the symptoms of Parkinsonism Trihexyphenidyl works by blocking the activity of acetylcholine, a neurotransmitter that is involved in motor control. It helps to restore the balance of neurotransmitters in the brain and alleviate the Parkinsonian symptoms caused by antipsychotic medication. Drugs that have high central: peripheral anticholinergic action are used in Drug-induced parkinsonism. They include: Trihexyphenidyl (Benzhexol). Procyclidine. Biperiden, Orphenadrine. Promethazine. Common side effects include urinary retention, acute confusion, blurring of vision (mydriasis), and euphoria (orphenadrine). Entacapone (Option B) is a COMT inhibitor that prevents dopamine degradation. Ropinirole and pramipexole (Option C and D) are non-ergot derivatives that are selective dopaminergic D2/D3 receptor agonists that are used in Parkinsonism disease itself. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 218, 219, 865, 871",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 14,
      "question": "Beta-blockers are ideally avoided in which of the following?",
      "options": {
        "A": "Essential tremors",
        "B": "Diabetes mellitus with hypertension",
        "C": "Angina pectoris",
        "D": "Migraine prophylaxis"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Diabetes mellitus with hypertension Explanation: Beta-blockers should be ideally avoided in diabetes mellitus with hypertension due to. Potential to mask symptoms of hypoglycemia and patients fail to recognise key symptoms of a hypoglycemic state and neglect getting appropriate treatment. Increased risk of hypoglycemic episodes, as glycogenolysis in the heart, skeletal muscles, and liver that occurs due to sympathetic stimulation is attenuated. Uses of beta-blockers Drug of choice Migraine prophylaxis (Option D) Essential tremors (Option A) Aortic dissection if they also have hypertension Other Uses Hypertension-second-line drugs Stable angina: Decrease the frequency of attacks and increase exercise tolerance. (Option C) Cardiac arrhythmias: Used in both supraventricular and ventricular arrhythmias. Congestive heart failure: Decreases mortality. Thyrotoxicosis: Propranolol controls the sympathetic symptoms Glaucoma: Timolol and Betaxolol are used. Hypertrophic Cardiomyopathy (Improves cardiac output). Myocardial infarction (Ml): Secondary prophylaxis of Ml and myocardial salvage during evolution of Ml (decreases mortality). Reference: KD Tripathi, Essentials of Pharmacology, 8th Edition, Page 159-160",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 15,
      "question": "Beta-blockers should be avoided in all except.",
      "options": {
        "A": "Asthma",
        "B": "Glaucoma",
        "C": "Bradycardia",
        "D": "Hypothyroidism"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Glaucoma Explanation: Glaucoma can be treated with beta-blockers , such as betaxolol. Betaxolol works by blocking beta-2 receptors in the ciliary body, reducing cAMP levels and thereby decreasing aqueous humor production. Types of beta-blocker Examples Uses Non-selective beta-blocker Propranolol, nadolol Hypertension Angina Arrhythmias Migraine prophylaxis Beta-1-selective blockers Metoprolol, Atenolol Hypertension Heart failure Arrhythmias Beta-1-with Alpha-1 blockade Carvedilol, Labetalol Hypertension Heart failure Post-MI Side effects of beta-blocker Cardiac side effects Precipitation of an acute MI. Sinus bradycardia and heart block. (Option C) Heart failure may exacerbate symptoms in patients with decompensated heart failure or preexisting myocardial dysfunction. Extracardiac side effects Increased airway resistance; hence, it is contraindicated in patients with asthma due to bronchospasm. (Option A) Exacerbation of peripheral artery disease and worsen claudication and precipitate Raynaud's disease. In Hypoglycemia, Beta-blockers mask the signs seen in a hypoglycemic patient, such as tachycardia. Hyperkalemia Depression, fatigue, and sexual dysfunction such as erectile dysfunction. Weight gain Hypothyroidism (Option D) is not an indication of beta-blockers; they can be used to provide symptomatic relief in hyperthyroidism. Reference: KD Tripathi, Essentials of pharmacology, 8th Edition, Pages 162, 163, and 165",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 16,
      "question": "A 72-year-old male presents with complaints of a weak urinary stream and frequent urination in small amounts and is on prazosin. He also mentions that he frequently feels light-headed and has low blood pressure. Which of the following alpha-blockers would you prefer to give him?",
      "options": {
        "A": "Alfuzosin",
        "B": "Terazosin",
        "C": "Tamsulosin",
        "D": "Doxazosin"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Tamsulosin Explanation: The patient presents with symptoms of benign prostatic hyperplasia (BPH) and is experiencing postural hypotension, likely due to prazosin, a non-selective alpha-1 antagonist that affects both vascular and urogenital alpha-1 receptors. Tamsulosin, an alpha-1A selective antagonist, primarily targets receptors in the prostate and bladder neck, improving urinary symptoms with minimal effects on blood pressure. This selectivity reduces the risk of postural hypotension Types Alpha blockers Non-competitive + irreversible type Phenoxybenzamine Competitive + reversible type Non- selective Phentolamine Ergotamine Ergotoxine Chlorpromazine Alpha 1 selective Drugs Location Effects Alpha 1 a Tamsulosin Silodosin Internal urethral sphincter and Iris Ejaculation failure/retrograde ejaculation, miosis, increased urine outflow Alpha 1 b Alfuzosin Doxazosin Prazosin Terazosin Vascular Smooth muscle Vasodilatation, reflex tachycardia, reduced GFR (thus leading to RAAS activation) Alpha 2 selective Yohimbine Idoxazon Central nervous system Penile erection (used in depression with sexual dysfunction) Alfuzosin (Option A), Terazosin (Option B) and Doxazosin (Option D): Block A1B receptors, decrease peripheral vascular resistance and lower arterial blood pressure by causing relaxation of both arterial and venous smooth muscle, but it does not increase urinary outflow thus cannot be used in BPH. Reference: KD Tripathi, Essentials of pharmacology, 8th Edition, Page 142, 154",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 17,
      "question": "A patient presents to the emergency department with diarrhea, sweating, excessive lacrimation, and salivation . His pulse rate is 55/min and his plasma cholinesterase level was 50U/mL . Which of the following can be used to treat this patient?",
      "options": {
        "A": "Neostigmine",
        "B": "Atropine",
        "C": "Epinephrine",
        "D": "Benztropine"
      },
      "correct_answer": "B",
      "explanation": "cholinergic toxicity or poisoning, which is caused by excessive stimulation of the cholinergic system. Atropine is an anticholinergic medication that can be used as an antidote in cases of cholinergic toxicity. Atropine works by blocking the effects of acetylcholine, the neurotransmitter responsible for cholinergic stimulation. By inhibiting acetylcholine, atropine helps counteract the excessive cholinergic activity and relieve symptoms. Incorrect Options: Option A - Neostigmine : Neostigmine is a cholinesterase inhibitor that increases cholinergic activity. It would exacerbate the symptoms in a patient with cholinergic toxicity and is not appropriate for treatment. Option C - Epinephrine : Epinephrine is a sympathomimetic agent that stimulates adrenergic receptors. It would not be effective in treating cholinergic toxicity. Option D - Benztropine : Benztropine is an anticholinergic medication used primarily for the treatment of Parkinson's disease and drug-induced extrapyramidal symptoms. While it has anticholinergic properties, it is not commonly used for the treatment of acute cholinergic toxicity. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 18,
      "question": "Which is the following drug that causes postural hypotension commonly ?",
      "options": {
        "A": "Beta blocker",
        "B": "Alpha blocker",
        "C": "ACE inhibitor",
        "D": "Angiotensin receptor blockers"
      },
      "correct_answer": "B",
      "explanation": "vasoconstrictors for Alpha receptors reduces peripheral resistance and causes blood pooling in capacitance vessels; venous return and cardiac output are reduced fall in BP. Postural reflex interferes with marked hypotension on standing, followed by dizziness and syncope. Hypovolemia accentuates the hypotension. Incorrect Options: Option A - Beta blockers: Beta 1 blocker cause Hypotension while Beta 2 blockers increase BP Option C - ACE inhibitor: Side effects of ACE inhibitor Are Hypotension especially common when starting the medication or when the dosage is increased, Dry cough, Angioedema, Hyperkalemia and skin rashes. Option D - Angiotensin receptor blockers: Side effects of Angiotensin receptor blockers Are Hypotension ,Angioedema, Hyperkalemia ,skin rashes and They may reduce blood supply to the kidneys and can cause a temporary increase in serum creatinine levels. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 19,
      "question": "Apart from mu-opioid receptors , on which other receptor does tramadol act?",
      "options": {
        "A": "Anticholinergic",
        "B": "5HT 1a inhibition",
        "C": "Serotonergic and norepinephrine reuptake inhibition",
        "D": "Antihistaminic"
      },
      "correct_answer": "C",
      "explanation": "serotonergic and norepinephrine reuptake inhibitor. Tramadol is a centrally acting analgesic that primarily binds to mu-opioid receptors to exert its pain-relieving effects. However, in addition to its opioid activity, tramadol also has the ability to inhibit the reuptake of serotonin and norepinephrine. By inhibiting the reuptake of these neurotransmitters, tramadol increases their availability in the synaptic cleft, leading to enhanced analgesic effects. This dual mechanism of action contributes to tramadol's unique pharmacological profile. Incorrect Options: Option A - Anticholinergic: Tramadol does not have anticholinergic activity. Anticholinergic drugs act by blocking the effects of acetylcholine at muscarinic receptors and are not relevant to tramadol's mechanism of action. Option B - 5HT 1a inhibition: Tramadol does not directly inhibit 5HT1a receptors. While it does affect serotonin levels through its reuptake inhibition, it is not specific to 5HT1a receptors. Option D - Antihistaminic: Tramadol does not possess significant antihistaminic activity. Antihistaminic drugs act by blocking the effects of histamine at histamine receptors and are not relevant to tramadol's mechanism of action. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 20,
      "question": "Which of the options below acts as a selective alpha-1 receptor antagonist in medical practice?",
      "options": {
        "A": "Phenoxybenzamine",
        "B": "Phentolamine",
        "C": "Prazosin",
        "D": "Idazoxan"
      },
      "correct_answer": "C",
      "explanation": "treatment of hypertension and benign prostatic hyperplasia (BPH). It selectively blocks alpha-1 receptors, leading to vasodilation and a decrease in blood pressure. Phenoxybenzamine (option A) : Phenoxybenzamine is a non-selective alpha blocker that blocks both alpha-1 and alpha-2 receptors. It is primarily used for managing pheochromocytoma but is not selective for alpha-1 receptors. Phentolamine (option B) : Phentolamine is a non-selective alpha blocker that also blocks both alpha-1 and alpha-2 receptors. It is used in the treatment of pheochromocytoma and acute hypertension but is not selective for alpha-1 receptors. Idazoxan (option D) : Idazoxan is an alpha-2 receptor antagonist , not an alpha-1 receptor antagonist, and is used primarily in research settings. Reference: https://www.ncbi.nlm.nih.gov/books/NBK539830/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 21,
      "question": "Chelator contraindicated in Iron poisoning?",
      "options": {
        "A": "Calcium disodium EDTA",
        "B": "Deferoxamine",
        "C": "British anti lewsite (BAL)",
        "D": "Penicillamine"
      },
      "correct_answer": "C",
      "explanation": "chelator primarily used for the treatment of heavy metal poisoning, specifically arsenic, mercury, and lead. Use in Iron Poisoning: BAL is contraindicated in iron poisoning because it is not effective for iron and can potentially displace iron from its chelation sites, worsening the situation. It does not effectively bind iron and could potentially complicate the clinical picture in iron toxicity. Incorrect Options: Option A - Calcium Disodium EDTA: Mechanism of Action: Calcium disodium EDTA (ethylenediaminetetraacetic acid) is a chelator used for lead poisoning and other heavy metals. While it is not the first choice for iron poisoning, it is used in some cases of iron overload to a limited extent. Use in Iron Poisoning: Calcium disodium EDTA is not typically used for iron poisoning, but it is not contraindicated. It is more commonly used for lead and other heavy metal poisonings. Option B - Deferoxamine: Mechanism of Action: Deferoxamine is a specific iron chelator that binds to free iron in the bloodstream and facilitates its excretion. Use in Iron Poisoning: Deferoxamine is the drug of choice for treating iron poisoning. It is effective in removing excess iron from the body and is specifically indicated for iron overload conditions. Option D - Penicillamine: Mechanism of Action: Penicillamine is a chelator used primarily for copper poisoning (e.g., Wilson's disease) and can also be used for lead poisoning. Use in Iron Poisoning: Penicillamine is generally not used for iron poisoning, but it is not contraindicated. It is less effective compared to deferoxamine for iron overload and is not the first choice.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 22,
      "question": "Example of SNRI antidepressant drug",
      "options": {
        "A": "Reboxatine",
        "B": "Tramadol",
        "C": "Paroxetine",
        "D": "Bupropion"
      },
      "correct_answer": "A",
      "explanation": "and is used as an antidepressant. It affects norepinephrine reuptake exclusively and does not significantly impact serotonin levels. Incorrect Options Option B - Tramadol: Tramadol is an analgesic with weak serotonin and norepinephrine reuptake inhibition properties but is not classified as a primary antidepressant or SNRI. It is mainly used for pain management, and its SNRI activity is a secondary effect rather than its primary indication. Option C - Paroxetine: Paroxetine is a selective serotonin reuptake inhibitor (SSRI). It primarily affects serotonin reuptake and does not significantly impact norepinephrine levels. Therefore, it is not classified as an SNRI. Option D - Bupropion: Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI). It primarily affects norepinephrine and dopamine reuptake, but does not significantly impact serotonin levels, so it is not classified as an SNRI.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 23,
      "question": "A 10-year-old child is diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and is started on medication to increase norepinephrine levels as part of the treatment plan. Which of the following drugs is used for this purpose, and what is its mechanism of action?",
      "options": {
        "A": "Methylphenidate",
        "B": "Reboxetine",
        "C": "Amitriptyline",
        "D": "Fluoxetine"
      },
      "correct_answer": "A",
      "explanation": "commonly used in the treatment of ADHD. It works by inhibiting the reuptake of both norepinephrine and dopamine, increasing their levels in the brain. This helps improve attention, focus, and impulse control in individuals with ADHD. Although Methylphenidate acts on both norepinephrine and dopamine, it is the increased norepinephrine that contributes significantly to its therapeutic effects in managing ADHD symptoms. Incorrect Options: Option B - Reboxetine: Reboxetine is a selective norepinephrine reuptake inhibitor (NRI) that increases norepinephrine levels by inhibiting its reuptake. While it does increase norepinephrine levels and could theoretically be used in ADHD, it is not commonly used for this purpose. Methylphenidate is preferred due to its established efficacy in ADHD treatment. Option C - Amitriptyline: Amitriptyline is a tricyclic antidepressant that inhibits the reuptake of both norepinephrine and serotonin. It is not typically used to treat ADHD, particularly in children, due to its side effect profile and the availability of more targeted medications like Methylphenidate. Option D - Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that primarily increases serotonin levels. It does not significantly affect norepinephrine levels and is not used to treat ADHD. Fluoxetine is mainly used to treat depression, anxiety, and other mood disorders.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 24,
      "question": "A 45-year-old patient has just undergone surgery and required a drug to reverse the muscle relaxation induced during the procedure. Which of the following drugs is used for this purpose?",
      "options": {
        "A": "Bethanechol",
        "B": "Atropine",
        "C": "Neostigmine",
        "D": "Edrophonium"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Neostigmine Explanation: Neostigmine is a cholinesterase inhibitor that is commonly used to reverse non-depolarizing muscle relaxants used during surgery. It works by inhibiting acetylcholinesterase at the neuromuscular junction, prolonging the action of acetylcholine and improving muscle strength. Uses of Neostigmine: Treatment of myasthenia gravis as it increases the availability of acetylcholine at neuromuscular junctions, thereby improving muscle strength. To reverse the effects of non-depolarizing neuromuscular blocking agents after surgical procedures. In managing urinary retention due to its ability to stimulate bladder muscle contractions. Cobra bites because cobra toxin disrupts the neuromuscular junction, resulting in respiratory paralysis. Bethanechol (Option A) is a cholinergic agonist that stimulates muscarinic receptors, which are found primarily in the urinary and gastrointestinal tracts. It is not used to reverse muscle relaxation after surgery because it does not affect the neuromuscular junction. Atropine (Option B) is a direct-acting anticholinergic (muscarinic antagonist) , blocking the action of acetylcholine at muscarinic receptors. It is used to treat bradycardia and to prevent the effects of excessive acetylcholine release. However, it does not reverse muscle relaxation. Edrophonium (Option D) is a short-acting acetylcholinesterase inhibitor and is used as a diagnostic tool in suspected cases of myasthenia gravis (Tensilon test). It is administered intravenously to individuals suspected of myasthenia gravis . It temporarily improves muscle strength, confirming the diagnosis by demonstrating impaired neuromuscular transmission due to acetylcholine receptor deficiency . Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 226",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 25,
      "question": "A female patient with a history of bronchial asthma has developed an acute attack of migraine. Which drug should be avoided?",
      "options": {
        "A": "Sumatriptan",
        "B": "Propranolol",
        "C": "Ergotamine",
        "D": "Lasmiditan"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Propranolol Explanation: Propranolol is a non-selective beta-blocker that blocks both beta-1 (found in the heart) and beta-2 receptors (found in the bronchial smooth muscle). Blocking beta-2 receptors can lead to bronchoconstriction , which can exacerbate symptoms in patients with bronchial asthma or lead to severe bronchospasm . Propranolol is contraindicated in patients with asthma due to its potential to worsen asthma symptoms, making it a poor choice in this scenario. Incorrect Options: Sumatriptan (Option A) is a 5HT1B/1D receptor agonist. It is used in patients who fail to respond to analgesics. It can cause coronary vasoconstriction, but it does not cause significant bronchoconstriction and is generally safe for use in asthma patients. Ergotamine (Option C) is an ergot alkaloid that is used to treat migraines by causing vasoconstriction. It does not directly cause bronchoconstriction like propranolol. Lasmiditan (Option D) is a 5-HT1F receptor agonist used as an alternative to triptans, especially for those with cardiovascular diseases, and it is not contraindicated for asthma. Reference: NIH Link",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 26,
      "question": "Which drug is used to test for Myasthenia Gravis?",
      "options": {
        "A": "Pyridostigmine",
        "B": "Neostigmine",
        "C": "Edrophonium",
        "D": "Atropine"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Edrophonium Explanation: A myasthenic crisis is characterized by severe muscle weakness that responds to edrophonium administration, while a cholinergic crisis does not improve with this drug. Edrophonium Test: Used to diagnose Myasthenia Gravis (MG) Principle: Edrophonium inhibits the enzyme acetylcholinesterase (AChE), which normally breaks down acetylcholine (ACh) at the neuromuscular junction. By inhibiting AChE, edrophonium increases acetylcholine levels, allowing it to interact more with the available acetylcholine receptors (AChRs) in the muscle, temporarily improving neuromuscular transmission and muscle strength in MG . Test Procedure: Initial Dose : Administer 2 mg IV of edrophonium . Evaluation : After 30 seconds, observe for improvement in muscle strength (e.g., in extraocular muscles, speech, or arm strength). Positive Test : If the patient shows improvement in muscle strength, the test is considered positive for MG and is terminated. Additional Dose : If no response occurs, give an additional 8 mg IV and observe again. Negative Result : If there is no improvement , MG is unlikely, but further testing may be needed to confirm the diagnosis Incorrect Options: Pyridostigmine (Option A) is an acetylcholinesterase inhibitor that is specifically used to increase acetylcholine activity at the neuromuscular junction and is used for the long-term treatment of Myasthenia Gravis rather than for diagnosis. Neostigmine (Option B) is also an acetylcholinesterase inhibitor and is used for the long-term treatment of Myasthenia Gravis rather than for diagnosis. Atropine (Option D) is a muscarinic antagonist used to treat bradycardia (low heart rate), and it is not involved in the diagnosis of Myasthenia Gravis. Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 1141-1143",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 27,
      "question": "Match the following: a. Beta 1. Indacaterol b. Beta 1 2. Mirabegron c. Beta 2 3. Isoproterenol d. Beta 3 4. Betaxolol",
      "options": {
        "A": "a-2, b-3, c-1, d-4",
        "B": "a-3, b-2, c-4, d-1",
        "C": "a-3, b-4, c-1, d-2",
        "D": "a-4, b-3, c-2, d-1"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - a-3, b-4, c-1, d-2 The correct matching is as follows: Receptors Drugs Beta Isoproterenol Beta 1 Betaxolol Beta 2 Indacaterol Beta 3 Mirabegron Mirabegron is a selective beta-3 adrenergic receptor agonist used primarily for the treatment of overactive bladder. The beta-3 adrenergic receptors are found primarily in the bladder smooth muscle. Betaxolol is a selective beta-1 adrenergic receptor antagonist. It is commonly used as an anti-hypertensive agent and also for the treatment of glaucoma. Beta-1 adrenergic receptors are found mainly in the heart. Isoprenaline (also known as isoproterenol) is a non-selective beta-adrenergic receptor agonist. It acts on both beta-1 and beta-2 adrenergic receptors. It is primarily used in emergencies to increase heart rate and cardiac output. Indacaterol, the first once-daily VLABA (Very Long-Acting β 2 Adrenergic Agonist) approved for COPD, is a potent β 2 agonist with high intrinsic efficacy. It has a fast onset of action, appears well tolerated, and is effective in COPD with little tachyphylaxis on continued use. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 263, 264.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 28,
      "question": "A chronic smoker was taking nicotine therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and developed a headache. What is the reason behind this?",
      "options": {
        "A": "Postural hypotension",
        "B": "Receptor downregulation",
        "C": "Rebound hypertension",
        "D": "Receptor hypersensitivity"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Rebound hypertension In the given scenario, the patient stopped taking clonidine tablets and now presents with a headache (a common symptom of rebound hypertension). Discontinuation of clonidine can cause rebound hypertension due to decreased alpha-2 adrenergic receptor activity, leading to increased sympathetic outflow and a subsequent rise in blood pressure. Clonidine: It is a centrally acting alpha-2 adrenergic receptor agonist commonly used to manage hypertension, opioid withdrawal, and smoking cessation. When used for smoking cessation, it helps to reduce the withdrawal symptoms associated with nicotine addiction, such as cravings, anxiety, and irritability. One of the side effects of clonidine therapy is rebound hypertensio n, which can occur when the drug is abruptly discontinued as alpha 1 receptors are upregulated. Rebound hypertension is characterized by a sudden and significant increase in blood pressure, which can cause symptoms such as headache, dizziness, and confusion. Postural hypotension (Option A) is characterized by a sudden drop in blood pressure upon standing up, which can cause dizziness and fainting . This is not the cause of the headache in this scenario, as per the patient’s symptoms. Receptor downregulation (Option B) is a phenomenon in which the number of receptors on the cell surface decreases in response to an increase in the stimulation of receptors. This is not the cause of the headache in this scenario, as the upregulation of receptors leads to rebound hypertension. Receptor hypersensitivity (Option D) is a condition in which the receptors on the cell surface become more sensitive to the ligand, which can result in an exaggerated response to the drug. This is not the cause of the headache in this scenario, as hypersensitivity of the receptors would not result in rebound hypertension or headache. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Page 636.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 29,
      "question": "A patient comes to the casualty with consumption of OPC pesticide. He was started on IV atropine infusion and pralidoxime. After 2 hours, the patient had a sudden rise in temperature. What is the cause of the fever?",
      "options": {
        "A": "Atropine toxicity",
        "B": "A side effect of pralidoxime",
        "C": "Due to organophosphate poisoning",
        "D": "Idiopathic"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Atropine toxicity The scenario described involves organophosphate (OP) poisoning , for which atropine and pralidoxime are used as treatment. The sudden onset of fever, in this case, is most likely a result of Atropine toxicity. Atropine works by blocking the action of acetylcholine at muscarinic receptors in the body. It also has other effects on the body, such as increased heart rate, pupil dilation, and drying secretions. These effects can lead to a rise in body temperature, which is known as atropine fever. It is the drug of choice (DOC) for OPC and carbamate poisoning, bradycardia and AV block . A side effect of pralidoxime (Option B): Pralidoxime, on the other hand, is used to reactivate acetylcholinesterase, the enzyme that is inhibited by organophosphate poisoning. It can cause side effects such as headache, dizziness, and blurred vision, but it is unlikely to cause fever. Due to organophosphate poisoning (Option C): Organophosphate poisoning can cause a range of symptoms such as muscle weakness, respiratory distress, and seizures, but it is not typically associated with fever. Idiopathic (Option D): Idiopathic fever refers to a fever of unknown cause, which is not the case in this scenario as the cause of the fever is likely related to atropine toxicity. Therefore, option d is also incorrect. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Page 217, 218",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 30,
      "question": "A young male patient presents with ptosis and muscle weakness, which reportedly worsens in the evening and improves in the morning. This is relieved by neostigmine. What is the likely diagnosis?",
      "options": {
        "A": "Myasthenia gravis",
        "B": "Huntington chorea",
        "C": "Amyotrophic lateral sclerosis",
        "D": "External ophthalmoplegia"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A - Myasthenia gravis: Myasthenia Gravis is a neuromuscular junction disease characterized by ptosis and muscle weakness that worsens in the evening and improves in the morning. Symptoms are relieved by anti-choline esterase, such as neostigmine. Pathophysiology Autoimmune disease is caused by antibodies targeting acetylcholine receptors at the neuromuscular junction. Disruption in neuromuscular transmission occurs through: Blockage of acetylcholine receptors. Complement-mediated inflammation leads to: Reduced receptor count. Damage to the end plate. Clinical features Fatigable muscle weakness: Muscle strength decreases with continued use, especially: Later in the day After exercise No sensory or CNS involvement, distinguishing it from other neurological disorders. Common Initial Symptoms: Ptosis (drooping eyelid) Diplopia (double vision) Weakness can spread to: Chewing, swallowing, and speaking muscles Limb muscles Diagnosis Tensilon (edrophonium) Test This involves the injection of Edrophonium (a short-acting anticholinesterase agent) into individuals with a deficiency of acetylcholine receptors at the neuromuscular junction. Steps: 2 mg i.v. Edrophonium → Observe for any adverse reactions → If no adverse reactions occur after 30–60 seconds, the remaining 8 mg is injected. If muscle strength improves after the administration of edrophonium, it indicates the presence of Myasthenia Gravis. Management Anticholinesterase agents (inhibit the breakdown of ACh by acetylcholinesterase and increase presynaptic levels of ACh, allowing for muscle contraction). Pyridostigmine (drug of choice) Neostigmine Ambenonium Huntington's chorea (Option B) is characterised by involuntary jerking movements and a decline in cognitive and psychiatric function. No ptosis or improvement with neostigmine. Amyotrophic lateral sclerosis (Option C) is characterised by progressive muscle weakness and atrophy. It has a mix of upper neuron and lower neuron signs in its presentation. Though ptosis may be seen, No improvement with neostigmine is seen. External ophthalmoplegia (Option D) is characterised by paralysis or weakness of the muscles that control eye movement, resulting in diplopia. No improvement with neostigmine is seen. Reference: Goodman & Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Page 230-231. Davidson’s Principles and Practice of Medicine, 24th Edition, Page 1141-1143",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 31,
      "question": "Unknown fruit consumption by a child, odd behaviour, fever and low urine output. Causative fruit and treatment is:",
      "options": {
        "A": "Datura - PAM",
        "B": "Datura - Physostigmine",
        "C": "Yellow oleander - Digibind",
        "D": "Yellow oleander - Physostigmine"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B) Datura - Physostigmine The scenario involves a child who consumed an unknown fruit and subsequently developed fever and decreased urine output, suggesting Datura Poisoning . The antidote for this condition is physostigmine. Datura contains hyoscine (scopolamine), hyoscyamine and traces of atropine Mechanism of Action: Initially, it stimulates the higher centers of the brain and then activates the motor centers. Later, it leads to depression of the vital centers in the medulla, resulting in paralysis. Clinical features: Dryness of mouth and throat Dysphagia Difficulty in talking Hoarseness of voice Flushed face Pupil dilatation Photophobia + Diplopia Agitation and restlessness Delirium Urinary retention Dry and hot skin Exfoliation of skin may occur Patients can end up in a coma, or death can occur due to respiratory paralysis. Treatment Gastrointestinal decontamination: Administer activated charcoal to absorb toxins. Use a cathartic if indicated. Antidote: Administer Physostigmine 1-2 mg IV slowl y, repeating as necessary based on symptom response. Symptomatic treatment: Consider Pilocarpine 5 mg subcutaneously for severe anticholinergic effects. Supportive care: Monitor vital signs and address any respiratory or cardiovascular issues. Reference: Essentials of Forensic Medicine and Toxicology, KS Narayan Reddy, 35th Edition, Page 454-455 Modern Medical Toxicology, by VV Pillai, 4th Edition, Page 209, 367, 368.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Ans_Pharmacology-Previous_Year_Questions_Q31_exp.jpg",
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 32,
      "question": "What treatment can be administered to a patient brought to the emergency department with symptoms of diarrhea, sweating, excessive lacrimation, salivation, a garlicky odor, a pulse rate of 55/min, and a plasma cholinesterase level of 50 U/mL?",
      "options": {
        "A": "Neostigmine",
        "B": "Atropine",
        "C": "Epinephrine",
        "D": "Benztropine"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Atropine The patient presents with symptoms consistent with cholinergic toxicity , which could result from exposure to organophosphates or other cholinergic agents. The key signs—diarrhea, sweating, lacrimation, salivation, a garlicky odor (common in organophosphate poisoning), and a low pulse rate (bradycardia)—suggest cholinergic overstimulation. Atropine , an anticholinergic drug, is the treatment of choice to counteract the excessive acetylcholine and relieve symptoms like bradycardia and excessive secretions. Organophosphate poisoning Common exposures Pesticide: Farmer/field worker, pediatric ingestion, suicide attempt Nerve agent: Multiple patients presenting with similar symptoms Manifestations Muscarinic (DUMBBELSS) : D- Diarrhea U- Urination M- Miosis B- Bronchospasms, bronchorrhea, bradycardia E- Excitation, Emesis L- Lacrimation S- Salivation, sweating Nicotinic: Muscle weakness, paralysis, fasciculations. Management Decontamination Atropine reverses muscarinic symptoms Pralidoxime reverses nicotinic and muscarinic symptoms (reactivates cholinesterase) Neostigmine (Option A) is an acetylcholinesterase inhibitor , which would worsen cholinergic toxicity by increasing acetylcholine levels. It is used in the treatment of myasthenia gravis, not poisoning. Epinephrine (Option C): While epinephrine may be used in certain acute allergic or anaphylactic reactions, it is not appropriate for cholinergic toxicity, where atropine is needed to block the effects of excessive acetylcholine. Benztropine (Option D) is an anticholinergic drug used primarily to treat Parkinson’s disease or drug-induced extrapyramidal symptoms, but it is not suitable for treating cholinergic toxicity. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 228-229",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 33,
      "question": "A man was brought to the emergency room after poisoning with an unknown substance. Muscarinic poisoning was suspected, and he was treated for the same. What is the possible presenting feature that led to the diagnosis?",
      "options": {
        "A": "Mydriasis",
        "B": "Diuresis",
        "C": "Muscle fasciculations",
        "D": "Bradycardia"
      },
      "correct_answer": "D",
      "explanation": "occurs due to the parasympathetic stimulation of the heart's muscarinic receptors. The most common causes of muscarinic poisoning are organophosphate insecticides, carbamate insecticides or nerve agents, which inhibit acetylcholinesteras.e Muscarinic receptors are a type of acetylcholine receptor that are found in various organs of the body, including the heart, lungs, and digestive system. Muscarinic poisoning leads to the accumulation of acetylcholine in the synaptic cleft, which can cause excessive stimulation of muscarinic receptors . Manifestations of Muscarinic poisoning (DUMBBELSS) : D- Diarrhea U- Urination M- Miosis B- Bronchospasms, bronchorrhea, bradycardia E- Excitation, Emesis L- Lacrimation S- Salivation, sweating Mydriasis (Option A) is typically seen in sympathomimetic toxicity or anticholinergic poisoning, not muscarinic poisoning. In muscarinic poisoning (parasympathetic nervous system), the pupils typically constrict (miosis). Diuresis (Option B) is not typically associated with muscarinic poisoning. However, it generally leads to symptoms like increased salivation and sweating, rather than diuresis. Muscle fasciculations (Option C) can occur in cases of acetylcholinesterase inhibitor poisoning, but they are not specific to muscarinic receptors and can also be seen with nicotinic receptor activation. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Pages 228, 229",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 34,
      "question": "A patient with erectile dysfunction is given sildenafil. The penile erectile function is found to be improved after the therapy. Which of the following mediates the action of sildenafil ?",
      "options": {
        "A": "cAMP",
        "B": "cGMP",
        "C": "Calcium",
        "D": "Phosphatidyl glycerol and inositol phosphate"
      },
      "correct_answer": "B",
      "explanation": "(cyclic guanosine monophosphate) pathway. Mechanism of action: Sildenafil ↓ Inhibits phosphodiesterase-5 (PDE-5) enzyme ↓ Prevents cGMP degradation ↓ Increases cytosolic cGMP levels ↓ Prolongs activation of GMP-dependent protein kinase ↓ Inhibits myosin light chain kinase dephosphorylation ↓ Smooth muscle relaxation in the corpus cavernosum ↓ Increased blood flow ↓ Sustained penile erection cAMP (Option A) plays a role in other pathways related to vasodilation, especially in adrenergic pathways (e.g., beta-adrenergic agonists like adrenaline), but it is not the primary mediator in sildenafil’s mechanism . Calcium (Option C): Drugs that influence calcium signalling are often involved in muscle contraction, vasoconstriction, or other processes requiring calcium influx. Some examples include calcium channel blockers. Sildenafil's action is not mediated through calcium. Phosphatidyl glycerol and inositol phosphate (Option D) are involved in the phosphoinositide signalling pathway. This signalling pathway involves the activation of G-protein-coupled receptors (GPCRs), which activate phospholipase C to produce inositol trisphosphate (IP I ) and diacylglycerol (DAG). These molecules mediate calcium release and other cellular responses. They do not mediate sildenafil’s action. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 155, 327-328, 601-602, 611-612.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 35,
      "question": "Which of the following drugs is a β 2 agonist? Dopexamine Dipivefrine Fenoldopam Mirabegron",
      "options": {
        "A": "1,2,3",
        "B": "4,3,2,1",
        "C": "1,2",
        "D": "3,4"
      },
      "correct_answer": "C",
      "explanation": "β 2 agonists from given options are Dopexamine and Dipivefrine , hence the correct answer is 1,2. β 2 agonists are drugs that specifically stimulate β 2 adrenergic receptors, they are primarily found in the smooth muscles of the bronchi (lungs), blood vessels, and other tissues. Activation of β 2 receptors typically leads to bronchodilation , vasodilation , and other effects like muscle relaxation . Dopexamine: It is a synthetic catecholamine structurally related to dopamine and has a strong β 2 agonist activity, moderate activity at DA1 and DA2 receptors, and β 1 agonist activity. It is used in shock and heart failure to improve heart function and renal perfusion. Dipivefrine: It is a prodrug of epinephrine (adrenaline), primarily used in the treatment of glaucoma . It metabolizes into epinephrine , and activates α and β receptors , leading to increased aqueous humor outflow in the eye and decreases the production of aqueous humor by vasoconstriction, thus lowering intraocular pressure. It has β 2 agonist activity but is mainly used for its effect on the eye. Fenoldopam: (Option A, B and D ruled out) It is a D1 receptor agonist, it has a moderate affinity for α 2 receptors, but no significant affinity for D2, α 1, or β adrenergic receptors. It is used as a rapidly acting vasodilator for short-term control in severe hypertension e.g., malignant hypertension with end-organ damage. (usually <48 hours), Mirabegron: (Option B and D ruled out) It is a β 3 adrenergic receptor agonist, which activates β 3 receptors in the detrusor muscle of the bladder, leading to detrusor muscle relaxation, increasing the bladder capacity and reducing the urgency to urinate. It is used to manage overactive bladder. It is a moderate CYP2D6 inhibitor, so care must be taken with drugs metabolized by CYP2D6 (e.g., digoxin, metoprolol). Reference: Goodman and Gilman Pharmacological Basis of Therapeutics edition 14, Pages 259 , 261, 264. NIH Link .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 36,
      "question": "What is the mechanism by which acetylcholine causes a decrease in the heart rate ?",
      "options": {
        "A": "Delayed diastolic depolarization",
        "B": "Increase in plateau",
        "C": "Decrease in preload",
        "D": "Increase in afterload"
      },
      "correct_answer": "A",
      "explanation": "depolarization of the sinoatrial (SA) node during the relaxation phase of the cardiac cycle (diastole). The gradual depolarization of the SA node is responsible for initiating each heartbeat. When acetylcholine binds to muscarinic receptors in the SA node, it activates a signaling pathway that increases potassium efflux from the cells, hyperpolarizing the cell membrane. This hyperpolarization delays the diastolic depolarization, leading to a decrease in heart rate. Incorrect Options: Option B - Increase in plateau: Acetylcholine does not cause an increase in the plateau phase. Instead, it primarily affects the pacemaker activity of the SA node and the conduction through the atrioventricular (AV) node, leading to a decrease in heart rate. Option C - Decrease in preload: Acetylcholine does not directly cause a decrease in preload. Instead, it primarily affects heart rate through its influence on the SA node and AV node. However, a decrease in heart rate may indirectly lead to a decrease in preload over time due to a longer diastolic filling period. Option D - Increase in afterload: Acetylcholine does not directly cause an increase in afterload. Its primary effect on heart rate is related to its action on the SA node and AV node. Changes in afterload are more influenced by factors such as arterial resistance, vascular tone, and conditions like hypertension. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 37,
      "question": "Which of the following cannot be used to decrease intraocular pressure in glaucoma ?",
      "options": {
        "A": "Dexamethasone",
        "B": "Acetazolamide",
        "C": "Apraclonidine",
        "D": "Mannitol"
      },
      "correct_answer": "A",
      "explanation": "typically used to decrease intraocular pressure in glaucoma. While corticosteroids can have anti-inflammatory effects and may be used in certain ocular conditions, they are not commonly prescribed as primary treatments for reducing intraocular pressure in glaucoma. Incorrect Options: Option B - Acetazolamide: Acetazolamide is a carbonic anhydrase inhibitor that can effectively lower intraocular pressure in glaucoma. It reduces the production of aqueous humour, thereby decreasing the pressure inside the eye. Option C - Apraclonidine: Apraclonidine is an alpha-adrenergic agonist that can be used to reduce intraocular pressure in glaucoma. It works by decreasing the production of aqueous humour and increasing the outflow of fluid from the eye. Option D - Mannitol: Mannitol is an osmotic diuretic that is sometimes used in acute glaucoma episodes to rapidly reduce intraocular pressure. It works by drawing fluid out of the eye, thereby lowering the pressure. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 38,
      "question": "Pilocarpine produces:",
      "options": {
        "A": "Active miosis",
        "B": "Active mydriasis",
        "C": "Passive miosis",
        "D": "Passive mydriasis"
      },
      "correct_answer": "A",
      "explanation": "receptors in the eye. When applied topically to the eye, pilocarpine causes the contraction of the iris sphincter muscle, leading to active miosis, which is the constriction of the pupil. Incorrect Options: Option B - Active mydriasis : Mydriasis refers to the dilation of the pupil. Pilocarpine actually has the opposite effect of mydriasis. It causes miosis, not mydriasis. Option C - Passive miosis : The term \"passive miosis\" is not commonly used in medical terminology. Miosis itself refers to the constriction of the pupil, which can be actively induced by pilocarpine. Option D - Passive mydriasis : Similar to option B, \"passive mydriasis\" is not a recognized term in medical practice. Mydriasis refers to the dilation of the pupil, which is not produced by pilocarpine. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 39,
      "question": "A 5-year-old male child is brought to the ophthalmology clinic by his mother with complaints of blurring of vision for one week. The patient further explains that he only has blurring of the far vision and has no problem in his near vision. The patient gives a history of no other abnormalities. For a detailed examination of the eye, the doctor uses a short-acting topical medication which also has a cycloplegic effect. Which of the following drug was used by the doctor in this case?",
      "options": {
        "A": "Atropine oral",
        "B": "Atropine eye ointment",
        "C": "Tropicamide eye drops",
        "D": "Phenylephrine eye drops"
      },
      "correct_answer": "C",
      "explanation": "medication with cycloplegic effect for a detailed examination of the child's eyes. Tropicamide is a commonly used cycloplegic and mydriatic agent that is often employed in ophthalmology clinics for diagnostic purposes. Tropicamide eye drops cause temporary paralysis of the ciliary muscle of the eye, resulting in cycloplegia (loss of accommodation) and mydriasis (pupil dilation). These effects allow for a more accurate examination of the patient's refractive error and the posterior segment of the eye. Incorrect Options: Option A - Atropine oral : Atropine is a potent anticholinergic medication with cycloplegic and mydriatic effects. However, in this case, the doctor used a topical medication for examination, not an oral formulation. Option B - Atropine eye ointment : Atropine eye ointment can be used as a topical cycloplegic agent, but it has a slower onset of action compared to eye drops. It is typically used for prolonged dilation and cycloplegia, such as in cases of uveitis or amblyopia treatment. In this case, where a detailed examination is needed, a short-acting eye drop would be more appropriate. Option D - Phenylephrine eye drops : Phenylephrine is a sympathomimetic medication that acts as a mydriatic (pupil dilation agent) by stimulating alpha-adrenergic receptors in the iris dilator muscle. While it can be used for pupillary dilation, it does not have cycloplegic effects. In this case, where cycloplegia is desired for a detailed examination, tropicamide eye drops would be a more suitable choice. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 40,
      "question": "Intravenous mannitol is used in ____________?",
      "options": {
        "A": "Pulmonary edema",
        "B": "Congestive cardiac failure",
        "C": "Acute kidney injury with anuria",
        "D": "Glaucoma"
      },
      "correct_answer": "D",
      "explanation": "treatment of acute episodes of increased intraocular pressure associated with glaucoma. It works by reducing the intraocular fluid volume and lowering intraocular pressure, providing temporary relief and protecting the optic nerve. Incorrect Options: Option A - Pulmonary edema : While mannitol may be used in the management of certain types of pulmonary edema, such as in cases of increased intracranial pressure or cerebral edema. Other interventions, such as diuretics and vasodilators, are typically used in the management of pulmonary edema. Option B - Congestive cardiac failure : Mannitol is not a standard treatment for congestive heart failure. The primary treatment for congestive heart failure involves medications that help improve cardiac function, reduce fluid retention, and manage symptoms. Option C - Acute kidney injury with anuria : Mannitol may be used in some cases of acute kidney injury to promote diuresis and maintain urine flow. However, its use in anuric kidney injury is limited, as there is no urine output to enhance. Other interventions, such as fluid management, hemodialysis, or other renal replacement therapies, are typically employed in the treatment of anuric kidney injury. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 41,
      "question": "What is the drug used to differentiate myasthenia gravis from cholinergic crisis ?",
      "options": {
        "A": "Obidoxime",
        "B": "Edrophonium",
        "C": "Donepezil",
        "D": "Atropine"
      },
      "correct_answer": "B",
      "explanation": "inhibitor used in the diagnosis of myasthenia gravis (MG) and to differentiate between MG and cholinergic crisis. In myasthenia gravis, there is a deficiency or dysfunction of acetylcholine receptors at the neuromuscular junction, leading to muscle weakness and fatigue. Edrophonium temporarily increases the concentration of acetylcholine in the synaptic cleft by inhibiting acetylcholinesterase , the enzyme responsible for its breakdown. If a patient with myasthenia gravis receives edrophonium and experiences a temporary improvement in muscle strength , it suggests a diagnosis of myasthenia gravis. On the other hand, in cholinergic crisis, there is an excess of acetylcholine due to overstimulation of cholinergic receptors. Administering edrophonium in cholinergic crisis can worsen symptoms and lead to further muscle weakness and respiratory compromise. Incorrect Option: Option A - Obidoxime : Obidoxime is an antidote used for the treatment of organophosphate poisoning, not for differentiating myasthenia gravis from cholinergic crisis. Option C - Donepezil : Donepezil is a long-acting acetylcholinesterase inhibitor used in the treatment of Alzheimer's disease and is not specifically used to differentiate myasthenia gravis from cholinergic crisis. Option D - Atropine : Atropine is an anticholinergic medication that blocks the effects of acetylcholine. It is used for the treatment of cholinergic crisis but does not help differentiate myasthenia gravis from cholinergic crisis Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 42,
      "question": "Which of the following antiglaucoma medications is unsafe in infants ?",
      "options": {
        "A": "Timolol",
        "B": "Brimonidine",
        "C": "Latanoprost",
        "D": "Dorzolamide"
      },
      "correct_answer": "B",
      "explanation": "of glaucoma. However, it has been associated with serious adverse effects, such as central nervous system depression, hypotension , and apnea in infants. Due to these risks, brimonidine is generally considered unsafe in infants. Incorrect Options: Option A - Timolol: Timolol is a beta-blocker commonly used in the treatment of glaucoma. While it is generally considered safe and effective for adults and older children, it can be used with caution in infants. Option C - Latanoprost : Latanoprost is a prostaglandin analog commonly used in the treatment of glaucoma. While it is generally safe and well-tolerated, it is important to use caution and follow appropriate dosage adjustments in infants. However, compared to brimonidine, latanoprost is considered safer in infants. Option D - Dorzolamide : Dorzolamide is a carbonic anhydrase inhibitor used in the treatment of glaucoma. It is generally well-tolerated and safe for use in infants. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 43,
      "question": "Immediate treatment of anaphylaxic shock is:",
      "options": {
        "A": "Hydrocortisone",
        "B": "Atropine",
        "C": "Adrenaline",
        "D": "Benzylpenicillin"
      },
      "correct_answer": "C",
      "explanation": "anaphylactic shock. It acts rapidly to counteract the severe symptoms of anaphylaxis. Adrenaline works by stimulating alpha and beta-adrenergic receptors, which helps to reverse systemic vasodilation, increase blood pressure, improve bronchial airflow, and relieve swelling and hives. It is typically administered via intramuscular injection into the thigh as soon as anaphylaxis is suspected. Incorrect Options: Option A - Hydrocortisone: Hydrocortisone is a corticosteroid medication with anti-inflammatory properties. While corticosteroids like hydrocortisone may be used as part of the overall treatment plan for anaphylaxis, they are not considered the immediate treatment. Corticosteroids help reduce inflammation and prevent delayed allergic reactions but act more slowly than adrenaline. Option B - Atropine: Atropine is an anticholinergic medication that can help counteract certain effects of anaphylaxis, such as bronchoconstriction. However, it is not considered the first-line treatment for anaphylactic shock. Atropine may be used in specific cases when there is severe bronchospasm or other specific indications. Option D - Benzylpenicillin: Benzylpenicillin, also known as penicillin G, is an antibiotic and is not indicated for the immediate treatment of anaphylactic shock. Anaphylaxis is typically caused by an allergic reaction to specific allergens, such as certain foods, medications, or insect stings, and requires immediate management with adrenaline. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 44,
      "question": "Mechanism of action of atropine in treatment of organophosphate poisoning is ?",
      "options": {
        "A": "It inhibits secretion of acetylcholine",
        "B": "It is reactivation of acetylcholinesterase enzyme",
        "C": "It has antimuscarinic activity",
        "D": "It is agonist of acetylcholine receptors"
      },
      "correct_answer": "C",
      "explanation": "context of organophosphate poisoning, is used as an antidote to counteract the excessive stimulation of acetylcholine receptors caused by organophosphate insecticides or nerve agents. Atropine acts as a competitive antagonist at muscarinic acetylcholine receptors , blocking the effects of excess acetylcholine and reversing the toxic symptoms . Incorrect Options: Option A - It inhibits secretion of acetylcholine: Atropine does not directly inhibit the secretion of acetylcholine but rather acts as an antagonist at acetylcholine receptors. Option B - It is a reactivator of acetylcholinesterase enzyme: Atropine does not reactivate acetylcholinesterase, the enzyme that breaks down acetylcholine. It works by blocking the effects of excessive acetylcholine stimulation. Option D - It is an agonist of acetylcholine receptors: Atropine is not an agonist of acetylcholine receptors. It acts as an antagonist, blocking the binding of acetylcholine to these receptors. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 45,
      "question": "What is the preferred medication for managing Alzheimer's disease?",
      "options": {
        "A": "Donepezil",
        "B": "Atropine",
        "C": "Physostigmine",
        "D": "Fluoxetine"
      },
      "correct_answer": "A",
      "explanation": "choice for the treatment of Alzheimer's disease . It helps improve cognitive function and slows down the progression of symptoms in patients with Alzheimer's disease. Incorrect Options: Option B - Atropine: Atropine is an anticholinergic medication that blocks the effects of acetylcholine. It is not used for the treatment of Alzheimer's disease and may worsen cognitive function in this population. Option C - Physostigmine: Physostigmine is a cholinesterase inhibitor used in the treatment of anticholinergic toxicity and certain other conditions. It is not the drug of choice for Alzheimer's disease. Option D - Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used for the treatment of depression and other psychiatric disorders. It is not indicated for the treatment of Alzheimer's disease. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 46,
      "question": "Which of the following is a long acting bronchodilator ?",
      "options": {
        "A": "Salbutamol",
        "B": "Terbutaline",
        "C": "Adrenaline",
        "D": "Formoterol"
      },
      "correct_answer": "D",
      "explanation": "asthma and chronic obstructive pulmonary disease (COPD). It has a longer duration of action compared to short-acting bronchodilators like Salbutamol. Incorrect Options: Option A - Salbutamol: Salbutamol is a short-acting bronchodilator commonly used for acute relief of bronchospasm. It has a shorter duration of action compared to Formoterol. Option B - Terbutaline: Terbutaline is another short-acting bronchodilator similar to Salbutamol. It is not a long-acting bronchodilator like Formoterol. Option C - Adrenaline : Adrenaline, also known as epinephrine, is a bronchodilator that can provide immediate relief in acute asthma attacks but is not considered a long-acting bronchodilator. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 47,
      "question": "Which drug is most likely to cause tremors with prolonged use?",
      "options": {
        "A": "Salbutamol",
        "B": "Propofol",
        "C": "Betaxolol",
        "D": "Timolol"
      },
      "correct_answer": "A",
      "explanation": "asthma and other respiratory conditions, can be associated with the development of tremors as a side effect. Incorrect Options: Option B - Propofol: Propofol is a sedative-hypnotic agent used for anesthesia. Long-term use of Propofol is not typically associated with the development of tremors. Option C - Betaxolol: Betaxolol is a beta-blocker medication primarily used for the treatment of high blood pressure and certain heart conditions. Tremors are not a commonly reported side effect of Betaxolol. Option D - Timolol: Timolol is also a beta-blocker used to treat conditions such as high blood pressure and glaucoma. While it can cause side effects, tremors are not commonly ssociated with its use. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 48,
      "question": "What is the possible cause of poisoning in a farmer who has a pin-point pupil and an increase in secretions?",
      "options": {
        "A": "Organophosphate poisoning",
        "B": "Dhatura poisoning",
        "C": "Opioid poisoning",
        "D": "Atropine poisoning"
      },
      "correct_answer": "A",
      "explanation": "presentation of Organophosphate poisoning. Anticholinesterases (anti-ChEs) or cholinesterase inhibitors suppress the cholinesterase enzyme. They primarily inhibit both acetyl ChE and butyryl ChE. Phosphoric acid (organophosphates) or carbamic acid (carbamates) esters are the two anticholinesterases. In addition to causing symptoms like nausea, vomiting, stomach cramps, diarrhea, miosis, sweating, increased salivary, tracheobronchial, and gastric secretions, muscarinic, nicotinic, and central effects can also result in symptoms like bronchospasm, hypotension, muscular twitching, weakness, convulsions, and coma. The death-causing paralysis of the respiratory system. Incorrect Options: Option B - Datura poisoning: Hallucinations, delirium, agitation, confusion, and disorientation can all result from datura toxicity. There may also be seizures. They also prevent acetylcholine from working, which causes symptoms like constipation, urine retention, dry mouth, hazy vision, and dilated pupils (mydriasis). Tachycardia, arrhythmias, and variations in blood pressure (both high and low blood pressure) can all result from datura intoxication. Option C - Opioid poisoning: The central nervous system can be suppressed by opioids, which can result in shallow breathing, respiratory stoppage, and lethargy. symptoms are constipation, nausea, vomiting, bradycardia, hypotension, and bradycardia are all typical signs of opioid intoxication. Skin that feels clammy and cool is common. Option D - Atropine poisoning: Dry mouth, lessened perspiration, dilated pupils (mydriasis), hazy eyesight, and urine retention are symptoms of atropine toxicity. Tachycardia, agitation, disorientation, delirium, hallucinations, constipation, discomfort in the abdomen, and flushed, dry, and heated skin are also present. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 49,
      "question": "What dose of epinephrine is used anaphylactic shock ?",
      "options": {
        "A": "1:10000 I.V. - 10 ml",
        "B": "1:1000 I.M. - 0.5 ml",
        "C": "1:1000 I.M. - 1 ml",
        "D": "1:1000 I.V.- 0.5 ml"
      },
      "correct_answer": "B",
      "explanation": "drug of choice as it helps reverse the severe allergic reaction and relieve symptoms. The recommended dose of epinephrine for anaphylactic shock is 1:1000 concentration, which means 1 mg of epinephrine in 1 mL of solution. It is administered intramuscularly (I.M.) in the mid-anterolateral aspect of the thigh. Incorrect Options: Option A - 1:10000 I.V. - 10 mL: Represents a more diluted concentration and a higher volume, which is not the standard dose for anaphylactic shock. Option C - 1:1000 I.M. - 1 mL: Represents a higher volume of epinephrine than the recommended dose. Option D - 1:1000 I.V. - 0.5 mL: Represents the correct concentration but the incorrect route of administration. Intravenous (I.V.) administration of epinephrine is reserved for severe cases and should be administered by healthcare professionals. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 50,
      "question": "A patient came to the causality with acute bronchial asthma after treatment for glaucoma . Which of the following is a most probable causative agent?",
      "options": {
        "A": "Timolol",
        "B": "Betaxolol",
        "C": "Latanoprost",
        "D": "Bimatoprost"
      },
      "correct_answer": "A",
      "explanation": "medication-induced bronchial asthma. Certain drugs used to treat glaucoma can cause bronchospasm in susceptible individuals. Timolol is a non- selective beta blocker commonly used to treat glaucoma by reducing intraocular pressure. However, it can also cause bronchospasm in patients with a history of asthma or chronic obstructive pulmonary disease (COPD). This is because beta blockers can block the beta-2 receptors in the lungs, which can lead to constriction of the airways. Incorrect Options: Option B - Betaxolol: Betaxolol is a beta-1 selective blocker that is used to treat glaucoma. It is less likely to cause bronchospasm than non-selective beta blockers like timolol. Option C - Latanoprost: Latanoprost is a prostaglandin analog used to treat glaucoma by increasing the outflow of aqueous humor from the eye. It does not directly affect the airways and is unlikely to cause bronchospasm. Option D - Bimatoprost: Bimatoprost is another prostaglandin analog used to treat glaucoma. Like latanoprost, it is unlikely to cause bronchospasm. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 51,
      "question": "Which among the following is a short-acting beta blocker ?",
      "options": {
        "A": "Nadolol",
        "B": "Propranolol",
        "C": "Esmolol",
        "D": "Atenolol"
      },
      "correct_answer": "C",
      "explanation": "heart rates or high blood pressure during surgery or other procedures. It has a half-life of only about 9 minutes, meaning its effects wear off quickly. Incorrect Options: Option A - Nadolol: Nadolol is a long-acting beta blocker taken once a day. It has a half-life of about 20-24 hours, meaning it stays in the body long. Nadolol treats high blood pressure, angina, and heart failure. Option B - Propranolol: Propranolol is a non-selective beta blocker used to treat high blood pressure, angina, migraines, and other conditions. It has a half-life of about 4-6 hours, which means it is a relatively short-acting agent. Option D - Atenolol: Atenolol is a selective beta-blocker for treating high blood pressure, angina, and other conditions. It has a half-life of about 6-7 hours, which means it is a relatively short-acting agent. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 52,
      "question": "Which of the following statements about the treatment of a farmer presenting with symptoms of diarrhea, sweating, excessive tearing, and salivation in the emergency department is not accurate?",
      "options": {
        "A": "Carbamates bind to acetylcholinesterase irreversibly.",
        "B": "Atropine is used as an antidote for OP poisoning",
        "C": "Pralidoxime has a role in reversing the enzyme in carbamate poisoning",
        "D": "Succinylcholine use is avoided in rapid sequence intubation"
      },
      "correct_answer": "C",
      "explanation": "statement is incorrect. Pralidoxime is an antidote for organophosphate poisoning, but it does not reverse the inhibition of acetylcholinesterase by carbamates. Pralidoxime is used for nicotinic effects of organophosphates. The scenario described in the question is consistent with organophosphate or carbamate poisoning. The symptoms are caused by the buildup of acetylcholine, a neurotransmitter, in the body. Incorrect Options: Option A - Carbamates bind to acetylcholinesterase irreversibly: This statement is true. Carbamates and organophosphates inhibit acetylcholinesterase, which leads to an accumulation of acetylcholine at nerve synapses and neuromuscular junctions. Carbamates bind to the enzyme irreversibly, whereas organophosphates bind reversibly. Option B - Atropine is used as an antidote for OP poisoning: This statement is true. Atropine is an antidote for organophosphate poisoning. It blocks the effects of excessive acetylcholine in the body but does not reverse the inhibition of acetylcholinesterase. Option D - Succinylcholine use is avoided in rapid sequence intubation: As Succinylcholine is a depolarizing neuromuscular blocking agent that can cause a rapid rise in potassium levels, leading to cardiac arrhythmias or cardiac arrest. Its use is generally avoided in patients with known or suspected hyperkalemia, severe burns, or skeletal muscle injury. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Previous Year Questions"
    }
  ]
}
